Access cutting-edge lung cancer treatment through this clinical trial at a research site in Evergreen Park. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Evergreen Park at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
Clinical study to investigate the efficacy and safety of savolitinib in combination with osimertinib versus platinum-based doublet chemotherapy in participants with EGFR mutated, MET-overexpressed and/or amplified, locally advanced or metastatic NSCLC who have progressed on treatment with Osimertinib.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Evergreen Park, IL
If you're searching for lung cancer treatment options in Evergreen Park, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Evergreen Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.